drugset / Trial / NCT07456488

The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group

NCT07456488

Phase 2 Recruiting 60 enrolled Liaquat National Hospital & Medical College
RandomizedParallel-groupSingle-blindPrevention

Summary

In this study, atropine 0.01% eye drops will be given to myopic children once at night daily for 6 months as compared to a control group to see the effect on axial length and refraction

Timeline

Start
2025-07-13
Primary completion
2026-04-17
Completion
2026-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 0.01 % Other

Indications

No indication recorded.